An albumin blood test measures the main protein produced by the liver. At Longevity Benchmark, we review clinical laboratory markers against peer-reviewed evidence to help readers evaluate their routine panels. The marker is part of the comprehensive metabolic panel and standard liver panel.
The Verdict
What Albumin Measures and the Normal Range
Albumin is the most abundant protein in human blood plasma, produced exclusively by hepatocytes at a rate of 9 to 12 grams daily. According to a World Journal of Gastrointestinal Surgery review, it accounts for approximately 60% of total serum protein by weight. Globulins comprise the remaining 40%. As MedlinePlus documents, albumin prevents fluid from leaking out of blood vessels into surrounding tissues. It generates the primary colloid osmotic pressure within the vascular system. When levels drop, fluid escapes. This extravasation produces swelling in the legs, abdomen, or lungs.
Albumin also acts as a carrier protein. It binds and transports hormones, vitamins, enzymes, calcium, and bilirubin through the bloodstream. Clinical laboratories measure albumin concentration using automated dye-binding assays. The World Journal of Gastrointestinal Surgery review notes that standard bromocresol dye can bind other serum proteins, occasionally overestimating true albumin levels.
Laboratory instruments and calibration protocols differ across regional networks. Always interpret your number against the specific reference interval printed on your laboratory report. Reference ranges reflect population distributions rather than personalized physiological targets. Our guide to normal versus optimal ranges explores that statistical distinction in detail.
| Source | Reference Range | Notes |
|---|---|---|
| MedlinePlus Encyclopedia | 3.4 to 5.4 g/dL (34 to 54 g/L) | Notes that reference ranges may vary slightly among laboratories. |
| Cleveland Clinic Albumin Page | 3.5 to 5.5 g/dL | Cleveland Clinic albumin page. |
| Cleveland Clinic Globulin Page | 3.9 to 4.9 g/dL | Cleveland Clinic globulin page. |
| American College of Gastroenterology Guideline | 3.5 g/dL or higher | Normal threshold cited in the 2017 liver chemistry guideline. |
Causes and Mechanisms Behind a Low Result
Hypoalbuminemia most frequently stems from systemic inflammation, critical illness, severe liver impairment, or renal protein loss. Systemic inflammation prompts a rapid reduction in circulating albumin concentrations. The American College of Gastroenterology (ACG) states that any severe illness can lower albumin through cytokine-mediated mechanisms. Researchers Soeters and colleagues explain that inflammatory signaling increases capillary permeability. Albumin escapes into the interstitial space. Concurrently, the circulating half-life of albumin shortens. Circulating levels can drop within hours of acute trauma or severe infection.
An American Academy of Family Physicians (AAFP) review notes that acute injury, burns, and infections create an acute-reaction pattern where albumin falls along with transferrin.
| Condition | Primary Mechanism | Clinical Context |
|---|---|---|
| Systemic inflammation and infection | Cytokines increase capillary permeability, driving albumin into tissue spaces while shortening its circulating lifespan | Seen in acute infections, trauma, burns, and chronic inflammatory states |
| Chronic liver disease | Reduced functional liver mass lowers albumin production | Observed in severe cirrhosis, active hepatitis, and steatotic liver disease |
| Nephrotic syndrome | Damaged glomerular filtration barriers allow large amounts of albumin to spill into the urine | Accompanied by proteinuria, peripheral edema, and elevated serum lipids |
| Protein-losing enteropathy | Protein lost through the gut (AAFP) | Associated with Crohn disease, celiac disease, or Whipple disease |
| Extensive burns | Burns over a large area (MedlinePlus) | Occurs in burns covering large body surface areas |
| Nutritional deficiency | Listed by MedlinePlus and Cleveland Clinic | Uncomplicated undernutrition causes little to no fall unless infection or inflammation is also present |
Causes Behind a High Result
A high albumin blood test result, termed hyperalbuminemia, almost universally indicates dehydration rather than hepatic overproduction. When intravascular fluid volume contracts, protein concentration rises mechanically. MedlinePlus and Cleveland Clinic identify severe diarrhea, and dehydration as primary triggers. Technical collection factors also influence measured concentrations. Leaving a tourniquet in place too long during venipuncture raises local venous pressure. Fluid exits the local capillary bed into interstitial tissues. Albumin remains trapped inside the vein, inflating the laboratory value.
Certain medications can also raise circulating levels. MedlinePlus Encyclopedia reports that anabolic steroids, androgens, growth hormone, and insulin can increase measured readings. MedlinePlus and Cleveland Clinic also list high-protein diets as a potential cause, though medical sources publish no quantifiable magnitude for this effect. Conversely, drinking too much water may cause abnormal results.
The Three-Week Circulating Half-Life
Serum albumin has a circulating half-life of 3 weeks, making it an insensitive measure of acute hepatic injury. The ACG clinical guideline emphasizes that this slow turnover delays measurable blood changes. A drop in albumin generally indicates liver dysfunction persisting for more than 3 weeks. Acute hepatocellular damage does not lower albumin immediately. For immediate assessment, prothrombin time provides a far more sensitive indicator of liver synthetic capacity. Prothrombin time can become prolonged in severe liver disease within 24 hours.
Albumin kinetics also govern the resolution of clinical jaundice. Delta bilirubin consists of bilirubin covalently bound to albumin molecules. This complex clears in step with albumin's 3-week half-life. Patients recovering from hepatitis or biliary obstruction frequently remain visibly jaundiced for weeks after liver injury resolves. For ongoing monitoring, Soeters and colleagues note that a rising or falling albumin trend serves as an adequate indicator that the clinical state is improving or worsening.
Albumin and Liver Function
Albumin reflects hepatic synthetic capacity rather than cellular damage, separating functional performance from enzyme leakage. Transaminases like ALT leak into serum when hepatocytes suffer acute membrane injury. In contrast, albumin measures the liver's actual production rate. This difference makes albumin central to any standard hepatic function panel.
An AAFP review on jaundice evaluation notes that low albumin and prolonged prothrombin time demonstrate hepatic decompensation. Clinical guidelines define no single albumin concentration as indicating liver failure. The ACG guideline defines acute liver failure by prolonged prothrombin time and hepatic encephalopathy in patients without prior liver disease. For chronic liver disease, clinicians calculate the Child-Turcotte-Pugh score. Albumin represents one of five scored variables. The remaining parameters are encephalopathy, ascites, bilirubin, and prothrombin time or INR. Within this scoring system, albumin above 3.5 g/dL assigns 1 point, 2.8 to 3.5 g/dL assigns 2 points, and below 2.8 g/dL assigns 3 points. Soeters and colleagues observe that albumin fractional synthesis rates decline only in true liver failure and possibly kwashiorkor, remaining normal or elevated in most other illnesses.
Albumin and Total Calcium Interpretation
Standard metabolic panels measure total serum calcium, but approximately 40% of circulating calcium travels bound to albumin. The remaining fraction circulates as free ionized calcium or bound to small anions like citrate. When albumin concentrations drop, total measured calcium declines in parallel.
To interpret low total calcium, clinicians traditionally applied correction formulas. The standard formula calculates corrected calcium as 0.8 multiplied by normal albumin minus patient albumin, added to measured total calcium. However, a review in the Journal of Hospital Medicine questions this approach. The authors found that correction formulas become increasingly inaccurate as hypoalbuminemia deepens. Large retrospective analyses revealed that corrected calcium predicted ionized calcium less reliably than uncorrected total calcium. In patients with renal failure or albumin below 3.0 g/dL, the calculation consistently overestimated actual calcium. The authors recommend ordering a direct ionized calcium assay whenever calcium values appear abnormal in patients with altered albumin.
Albumin in Chronic Illness and Mortality
Epidemiological cohorts establish strong observational links between lower serum albumin levels and increased risks of hospital admission and all-cause mortality. In the Atherosclerosis Risk in Communities (ARIC) study, investigators followed 4,947 community-dwelling adults with a mean age of 75.5 years over a median of 4.42 years. Mean baseline albumin was 4.05 g/dL. After adjusting for demographics, kidney function, and inflammatory markers like high-sensitivity CRP, each 1 g/dL lower baseline albumin was associated with a hazard ratio of 1.67 for death. The incidence rate ratio for hospitalization was 1.58. Earlier studies cited by ARIC estimated that each standard deviation decline in albumin increased the odds of death by 24% to 47%. The ARIC authors note albumin may partly serve as a proxy for physical frailty. These statistical associations weakened among the oldest participants.
Malignancy cohorts show similar patterns. The World Journal of Gastrointestinal Surgery review notes a high prevalence of hypoalbuminemia among individuals with cancer. Serum albumin is an independent prognostic factor for survival in melanoma, breast, colorectal, gastric, lung, and pancreatic cancers. A systematic review by Gupta and Lis found that 26 of 29 studies in gastrointestinal cancers linked higher albumin to improved survival. Most of those studies employed a threshold of 3.5 g/dL. The review states that the primary mechanism for low albumin in cancer remains unclear. Proposed drivers include tumor-produced cytokines like IL-6, vascular hyperpermeability, and altered protein degradation. Soeters and colleagues add that hypoalbuminemia frequently correlates with chemotherapy failure and mortality.
Approaches to Raising a Low Result
Normalizing a low serum albumin result requires identifying and managing the underlying clinical condition rather than consuming protein supplements. Cleveland Clinic emphasizes that medical therapy depends entirely on the root cause. Addressing the primary disease state allows endogenous liver production to recover while curbing systemic capillary leakage. When renal damage drives albumin loss, clinical attention shifts to protecting glomerular filtration. Persistent urinary loss is evaluated through kidney markers like estimated glomerular filtration rate. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) identifies a urine albumin-to-creatinine ratio exceeding 30 mg/g as abnormal albuminuria.
In critical care, intravenous albumin administration does not reliably improve patient outcomes. Soeters and colleagues observe that albumin infusions in intensive care fail to reduce infection rates, fluid requirements, or mortality. Clearer evidence of clinical utility appears in individuals with tense ascites secondary to portal hypertension. Dietary planning supports general physiological resilience. Broad macronutrient strategies are outlined in our overview of protein timing. Even so, increasing dietary protein intake will not correct hypoalbuminemia while active inflammatory signaling persists. If your recent panel flagged an abnormal value, schedule a follow-up review with your physician to evaluate your albumin blood test alongside a complete metabolic panel and urinalysis.
Frequently Asked Questions
What is worse, high or low albumin?
No clinical source we use ranks high and low albumin directly against each other. High albumin usually reflects dehydration, while low albumin is associated with systemic inflammation, chronic liver disease, nephrotic syndrome, and higher rates of hospitalization and mortality in cohort studies such as ARIC.
What level of albumin indicates liver failure?
Clinical guidelines do not define liver failure by a single albumin cutoff. The American College of Gastroenterology defines acute liver failure by prolonged prothrombin time and hepatic encephalopathy in a patient without prior liver disease. Albumin's 3-week half-life also makes it slow to fall (ACG). In chronic liver disease, albumin is evaluated as one of five factors in the Child-Turcotte-Pugh score, where levels above 3.5 g/dL score 1 point, 2.8 to 3.5 g/dL score 2 points, and levels below 2.8 g/dL score 3 points alongside ascites, encephalopathy, bilirubin, and prothrombin time.
What does it mean if my albumin is high?
A high albumin blood test result, known as hyperalbuminemia, most commonly indicates dehydration. When blood plasma volume falls due to poor fluid intake, severe diarrhea, or fluid loss, the concentration of albumin mechanically rises. Leaving a tourniquet on the arm for a prolonged period during the blood draw can also cause a falsely high reading. Less common causes include certain medications like anabolic steroids, androgens, growth hormone, or insulin. Clinical sources note that high-protein diets may contribute to higher levels, though without a defined magnitude.
What happens if albumin is low?
When serum albumin drops significantly, the blood loses colloid osmotic pressure, allowing fluid to leak from blood vessels into surrounding tissues. Cleveland Clinic lists symptoms of hypoalbuminemia that include swelling in the feet and legs, loss of appetite, fatigue, difficulty breathing, muscle weakness, and dark urine. Because albumin transports hormones, vitamins, and minerals, low levels also lower total measured blood calcium. Prolonged hypoalbuminemia also reflects underlying conditions such as chronic kidney disease, severe liver disease, protein-losing enteropathies, or systemic inflammation.
How do I raise my albumin level?
Raising a low albumin level requires working with a physician to identify and treat the underlying medical condition. Because low albumin is primarily driven by systemic inflammation, acute infection, liver impairment, or urinary or digestive protein loss, dietary protein supplements and protein powders do not directly raise serum levels while inflammation remains active. When inflammatory conditions or kidney losses are medically controlled, liver synthesis can restore circulating concentrations. In intensive care settings, intravenous albumin infusions have not been shown to lower mortality or fluid requirements, though they provide benefit in patients with tense ascites from portal hypertension.
What cancers cause low albumin?
Research reviews do not claim that specific cancers directly cause low albumin, except for primary liver cancer impairing protein production. Instead, observational studies document a high prevalence of hypoalbuminemia across many malignancies. Serum albumin is recognized as an independent prognostic factor for survival in colorectal, gastric, pancreatic, lung, breast, and melanoma cancers. A systematic review found that in 26 of 29 gastrointestinal cancer studies, higher albumin was associated with better survival. Researchers propose that tumor-generated cytokines such as IL-6, increased vascular permeability, and altered protein breakdown drive these low levels.